Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for EEG Sedation in Children with Behavioral Disorders
NCT03799783Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria di Padova
- Start
- Mar 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in Procedural sedation (PS), sponsored by Azienda Ospedaliero-Universitaria di Padova. Started Mar 2018; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT03799783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03799783.